Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NRXS is expected to report earnings to fall 53.12% to -15 cents per share on April 09
Q4'23
Est.
$-0.15
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on May 22 showed earnings per share of -31 cents, missing the estimate of -10 cents. With 6.76K shares outstanding, the current market capitalization sits at 15.51M.